1|t| A Multicenter, Open-Label, Safety Study of Meloxicam SoluMatrixâ„¢ Capsules in Subjects With Osteoarthritis of the Knee or Hip
1|a| The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip
